An Open Label Phase I Clinical Trial to Evaluate the Effect of Late Boost on HIV-uninfected Vaccinees From EV06 Trial
Latest Information Update: 05 Nov 2021
At a glance
- Drugs HIV DNA vaccine (Primary) ; HIV gp120 vaccine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics
- 06 Feb 2019 Status changed from active, no longer recruiting to completed.
- 08 Jan 2018 New trial record